Showing results (131-140 of 154) with videos related to
Sort By:
Pageof 16
Journal of Molecular Biology|September 13, 2002
Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactionsKatrin Sichler, David W Banner, Allan D'Arcy, et al.Journal of Medicinal Chemistry|June 1, 2001
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitorsC Apfel, D W Banner, D Bur, et al.Chemmedchem|September 27, 2006
Mapping the fluorophilicity of a hydrophobic pocket: synthesis and biological evaluation of tricyclic thrombin inhibitors directing fluorinated alkyl groups into the p pocketAnja Hoffmann-Röder, Eliane Schweizer, Jonas Egger, et al.Journal of Medicinal Chemistry|November 11, 1994
Design and synthesis of potent and highly selective thrombin inhibitorsK Hilpert, J Ackermann, D W Banner, et al.Organic & Biomolecular Chemistry|April 24, 2004
A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactionsJacob Olsen, Paul Seiler, Björn Wagner, et al.Organic & Biomolecular Chemistry|June 10, 2006
Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitorsEliane Schweizer, Anja Hoffmann-Röder, Jacob A Olsen, et al.Chemmedchem|May 10, 2013
Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin LVeronika Ehmke, Edwin Winkler, David W Banner, et al.Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Design of selective phenylglycine amide tissue factor/factor VIIa inhibitorsKatrin Groebke Zbinden, David W Banner, Jean Ackermann, et al.Bioorganic & Medicinal Chemistry|April 20, 2006
Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensityKatrin Groebke Zbinden, David W Banner, Kurt Hilpert, et al.Structure (London, England : 1993)|April 18, 2006
The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatmentArne C Rufer, Ralf Thoma, Jörg Benz, et al.Pageof 16